Kiora Pharmaceuticals Inc — 貸借対照表 (NASDAQ:KPRX)

Financials

総資産 15.16 M18.06 M18.68 M13.71 M36.48 M24.25 M 負債合計 8.16 M8.83 M7.27 M7.6 M10.72 M8.13 M 純資産合計 7 M9.22 M11.41 M6.11 M25.76 M16.13 M 負債および純資産合計 15.16 M18.06 M18.68 M13.71 M36.48 M24.25 M 有利子負債合計 280.01 K278.19 K———— 純負債 -823.56 K-7.37 M————

ニュース

キオラ・ファーマシューティカルズ、網膜専門医を顧問委員会に追加

Kiora Pharmaceuticals adds retina specialist to advisory board

キオーラ・ファーマシューティカルズ、KIO-100製剤の新特許を取得

Kiora Pharmaceuticals receives new patent for KIO-100 formulations

キオラ・ファーマシューティカルズ、第3四半期決算を発表、網膜疾患治療薬の臨床試験が進展

Kiora Pharmaceuticals reports Q3 results, advances retinal disease trials

Kiora joins RARE-X Vision Consortium to advance rare eye disease research

Kiora pharma reports Q2 results, advances retinal disease trials

Vicarious Surgical appoints Stephen From as new CEO

Kiora Pharmaceuticals stock rises after receiving patent for KIO-104

Kiora Pharmaceuticals receives patent for ocular disease treatment

Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know